Alon Vitenshtein

Alon Vitenshtein is a seasoned scientist currently serving as a Senior Scientist at Nectin Therapeutics since October 2021. Prior to this role, Alon held the position of Senior Scientist at EdiTy Therapeutics from October 2020 to November 2021. As a co-founder and Chief Business Officer at Academix.bio from 2017 to October 2020, Alon directed product and business model innovation, successfully acquired major pharmaceutical clients, and led numerous financing rounds for the company. Alon also co-founded LabWorm.com in 2016, establishing a platform for bioinformatics tools in the life sciences. Alon's academic experience includes teaching assistantship roles at Hadassah Academic College and Technion - Israel Institute of Technology. Alon earned a PhD in Innate and NK cell immunology from The Hebrew University of Jerusalem and holds a Master's degree in T-Cell Immunology and Autoimmunity, as well as a Bachelor of Arts in Molecular Biology, graduating Summa Cum Laude.